| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-004-1772-3 |
| P698 | PubMed publication ID | 15007531 |
| P50 | author | James David Jentsch | Q29667844 |
| P2093 | author name string | Luigi A Anzivino | |
| P2860 | cites work | NMDA receptor regulation of memory and behavior in humans | Q28208543 |
| Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats | Q28280906 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Recent advances in the phencyclidine model of schizophrenia | Q29618917 | ||
| The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia | Q33537860 | ||
| Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity | Q33651662 | ||
| NMDA receptor hypofunction model of schizophrenia | Q33813143 | ||
| Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia | Q34456339 | ||
| Glutamatergic mechanisms in schizophrenia | Q34504043 | ||
| Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices | Q35754781 | ||
| Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey | Q39680193 | ||
| Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. | Q40644096 | ||
| Schizophrenia and glutamatergic transmission | Q41690988 | ||
| N-methyl-D-aspartate receptors and information processing: human choice reaction time under a subanaesthetic dose of ketamine | Q43571784 | ||
| Modulation of MK-801-induced behaviour by noradrenergic agents in mice | Q43583552 | ||
| Clinical and sensorimotor gating effects of ketamine in normals | Q43621132 | ||
| Guanfacine treatment of cognitive impairment in schizophrenia | Q43719756 | ||
| Differential effects of delta 9-THC on spatial reference and working memory in mice | Q43761949 | ||
| Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. | Q43926190 | ||
| Genetic vasopressin deficiency facilitates performance of a lateralized reaction-time task: altered attention and motor processes. | Q44013503 | ||
| Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia | Q44045578 | ||
| Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. | Q44111438 | ||
| Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist properties | Q44918905 | ||
| Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons | Q48001290 | ||
| Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801. | Q48097121 | ||
| Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists | Q48114938 | ||
| Interactions of clonidine with phencyclidine and ketamine: studies of radial maze performance and righting reflex in rats | Q48233397 | ||
| Sex-related differences in spatial divided attention and motor impulsivity in rats | Q48373078 | ||
| Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates | Q48427318 | ||
| Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention | Q48520680 | ||
| Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex | Q48574685 | ||
| Decreased sensory responsiveness of noradrenergic neurons in the rat locus coeruleus following phencyclidine or dizocilpine (MK-801): role of NMDA antagonism | Q48591487 | ||
| Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting | Q48643180 | ||
| Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism | Q48678894 | ||
| Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats | Q48737054 | ||
| The effects of a sub-anaesthetic dose of ketamine on human selective attention. | Q50497639 | ||
| Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats. | Q51414370 | ||
| Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. | Q51481467 | ||
| NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. | Q51572162 | ||
| Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats. | Q51853448 | ||
| Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings. | Q52120927 | ||
| Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. | Q52144163 | ||
| Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response | Q68988854 | ||
| alpha 2 adrenergic agonists prevent MK-801 neurotoxicity | Q71781985 | ||
| Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex | Q72334786 | ||
| Working memory tasks in five-choice operant chambers: use of relative and absolute spatial memories | Q72421269 | ||
| The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine | Q73093995 | ||
| Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention | Q74075972 | ||
| Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers | Q78244138 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attention | Q6501338 |
| P304 | page(s) | 76-83 | |
| P577 | publication date | 2004-03-06 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats | |
| P478 | volume | 175 |
| Q38705413 | 1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice. |
| Q45267846 | Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats |
| Q36609334 | Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse |
| Q42083254 | Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype |
| Q40307940 | Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism |
| Q28542801 | Clonidine treatment delays postnatal motor development and blocks short-term memory in young mice |
| Q46017020 | Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. |
| Q50952803 | Differential effects of acute amphetamine and phencyclidine treatment and withdrawal from repeated amphetamine or phencyclidine treatment on social interaction and social memory in rats. |
| Q33976994 | Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia |
| Q36860053 | Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? |
| Q35226150 | Effects of the alpha-2 adrenoceptor agonist guanfacine on attention and working memory in aged non-human primates |
| Q37354597 | Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment |
| Q39674218 | Involvement of medial prefrontal cortex alpha-2 adrenoceptors on memory acquisition deficit induced by arachidonylcyclopropylamide, a cannabinoid CB1 receptor agonist, in rats; possible involvement of Ca2+ channels |
| Q41243157 | Noradrenergic modulation of risk/reward decision making |
| Q37595873 | Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus |
| Q40086274 | On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists |
| Q34661221 | Pharmacological enhancement of memory and executive functioning in laboratory animals. |
| Q39998926 | Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia |
| Q38930402 | Preclinical laboratory assessments of predictors of social rank in female cynomolgus monkeys |
| Q37469310 | The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss |
| Q38635337 | Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective |
| Q30489404 | Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia |
Search more.